In Slovenia, the current national drug strategy stipulates that drug treatment must be comprehensive, ensure continuity of care and be accessible to all drug users. Responsibility for implementing treatment lies predominantly at the national level, and drug treatment is provided by different systems of health, social support and civil society NGOs.
The Health Insurance Institute of Slovenia funds drug treatment in the health sector, and treatment is free of charge to the client. The treatment programmes delivered through the social care system are mainly funded by the Ministry of Labour, Family, Social Affairs and Equal Opportunities and the municipalities, or by other external resources, and may include a co-payment from clients.
Drug-related outpatient treatment is available through the national network of public CPTDAs and from the Centre for the Treatment of Drug Addiction at the Ljubljana
Drug treatment in Slovenia settings and number treated
NBYear of data 2015.
Trends in percentage of clients entering specialised drug treatment, by primary drug, in Slovenia
NB Year of data 2015.
Opioid substitution treatment in Slovenia proportions of clients in OST by medication and trends of the total number of clients
NBYear of data 2015. SROM: Slow-release oral morphine.
Psychiatric Hospital. The latter also provides inpatient treatment. Other psychiatric hospitals and psychiatric outpatient units within the primary healthcare system can also provide drug treatment. NGOs within the framework and funding of social welfare programmes are involved mainly in the provision of treatment communities and nonhospital- based residential treatment programmes.
The available treatment modalities include detoxification; psychosocial interventions; opioid substitution treatment (OST) and other medically assisted treatments; individual or group counselling with a sociotherapy or psychotherapy component, including assistance with rehabilitation and social reintegration; and links to home nursing, therapeutic communities and self-help groups. An integrated treatment programme for drug users with mental comorbidities is available at the Ljubljana Psychiatric Hospital.
OST is provided only by the CPTDAs and is free of charge to clients. Methadone was first introduced in 1990, while buprenorphine was registered in 2004, slowrelease morphine in 2005 and buprenorphine/naloxone combination in 2007.
In Slovenia, the majority of clients who received drug treatment in 2015 were treated in outpatient settings, with low-threshold facilities playing an important role as a first point of access to more specialised treatment services for high-risk drugs users
Treatment demand data are provided only by the specialised treatment centres. The majority clients admitted to treatment in 2015 did so as a result of opioid, mainly heroin, use, although treatment requests linked to opioid use have more than halved in the last decade. However, in 2015, the proportion of those who entered treatment who did so because of cannabis use increased among both new treatment clients and all treatment clients.
Opioid users remain the main clients of the Slovenian treatment system and, in 2015, many of them received OST; methadone remains the most commonly used OST medication.